Curcumin Formulations and Trials: What’s New in Neurological Diseases
Curcumin’s pharmacological properties and its possible benefits for neurological diseases and dementia have been much debated. In vitro experiments show that curcumin modulates several key physiological pathways of importance for neurology. However, in vivo studies have not always matched expectatio...
Main Authors: | Stella Gagliardi, Carlo Morasso, Polychronis Stivaktakis, Cecilia Pandini, Veronica Tinelli, Aristides Tsatsakis, Davide Prosperi, Miriam Hickey, Fabio Corsi, Cristina Cereda |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-11-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/25/22/5389 |
Similar Items
-
Nano Encapsulated Curcumin: And Its Potential for Biomedical Applications
by: Chen Y, et al.
Published: (2020-05-01) -
Curcumin and butyrate induce fibroblast senescence without the emergence of fibrosis biomarkers
by: Siwei Chu, et al.
Published: (2023-12-01) -
Recent advances in nanoformulations for co-delivery of curcumin and chemotherapeutic drugs
by: Maryam Hashemi, et al.
Published: (2017-01-01) -
Exploring the anti-inflammatory effects of curcumin encapsulated within ferritin nanocages: a comprehensive in vivo and in vitro study in Alzheimer’s disease
by: Carlo Morasso, et al.
Published: (2024-11-01) -
Enhancing the Bioavailability and Bioactivity of Curcumin for Disease Prevention and Treatment
by: Caroline Bertoncini-Silva, et al.
Published: (2024-03-01)